Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • ELCC 2018

    The 8th European Lung Cancer Conference

    Access to all presentations that took place at ELCC 2018 in Geneva, Switzerland

    Presentation Date(s):  
    • Apr 11 - 14, 2018
    • Total Presentations: 407

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    First line for non-oncogene addicted lung cancer

    • Type: Educational session
    • Presentations: 5
    • Moderators:M. Reck
    • Coordinates: 4/11/2018, 16:30 - 18:00, Room B
    • +

      First-line chemotherapy in NSCLC: Where do we stand?

      16:30 - 16:50  |  Presenter: R.A. Stahel

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Immunotherapy in the first-line setting: What have we achieved?

      16:50 - 17:10  |  Presenter: M. Reck

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      First-line therapy in PS2 and elderly patients: Any new signals?

      17:10 - 17:30  |  Presenter: E. Quoix

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      First-line therapy: What might we expect for the future?

      17:30 - 17:50  |  Presenter: G. Scagliotti

      • Abstract

      No abstract available for this presentation

    • +

      Q&A

      17:50 - 18:00

      • Abstract

      No abstract available for this presentation

  • +

    Immunotherapy and next-generation TKIs: From second to frontline treatment

    • Type: Poster Discussion session
    • Presentations: 18
    • +

      134PD - Primary PFS and safety analyses of a randomized phase III study of carboplatin + paclitaxel +/− bevacizumab, with or without atezolizumab in 1L non-squamous metastatic NSCLC (IMpower150)

      10:54 - 10:54  |  Presenter: M. Reck

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    New approaches in rare thoracic tumors

    • Type: Proffered Paper session
    • Presentations: 6
    • Moderators:M. Perol
    • Coordinates: 4/13/2018, 11:00 - 12:30, Room A
    • +

      213O - Nintedanib + pemetrexed/cisplatin in malignant pleural mesothelioma (MPM): Phase II biomarker data from the LUME Meso study

      11:40 - 11:55  |  Presenter: N. Pavlakis

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Poster Display session (Friday)

    • Type: Poster Display session
    • Presentations: 197
    • Coordinates: 4/13/2018, 12:30 - 13:00, Hall 1
    • +

      188P - Treatment switching–adjusted overall survival (OS) in KEYNOTE-024: First-line pembrolizumab versus chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)

      12:50 - 12:50  |  Presenter: M. Reck

      • Abstract

      Loading...

    • +

      194TiP - eXalt3: Phase 3 randomized study comparing ensartinib to crizotinib in anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) patients

      12:50 - 12:50  |  Presenter: L. Horn

      • Abstract

      Loading...

  • +

    Keynote lecture

    • Type: Keynote Lecture
    • Presentations: 1
    • Moderators:M. Reck
    • Coordinates: 4/13/2018, 14:10 - 14:40, Room B